Does a stage IA left‑sided breast cancer survivor who had a left mastectomy, completed four cycles of intravenous chemotherapy and a ten‑year course of oral chemotherapy, and is now three years post‑treatment, need a screening mammogram of the remaining right breast despite recent whole‑body CT and breast ultrasound?

Mammography of the Right Breast is Recommended

Yes, annual mammography of the remaining right (contralateral) breast is absolutely indicated and should be performed regardless of the recent whole-body CT and breast ultrasound. 1, 2, 1

Why Mammography is Essential

The ACS/ASCO Breast Cancer Survivorship Care Guidelines explicitly state that women who have received a unilateral mastectomy should undergo annual mammography on the intact breast 1, 2, 1. This recommendation is based on the need to:

• Detect new primary breast cancers in the remaining breast (contralateral breast cancer risk is approximately 0.5-1% per year)
• Identify early-stage disease when treatment is most effective and survival outcomes are best
• Provide the only imaging modality proven to improve survival in breast cancer survivors 3

Why CT and Ultrasound Don't Replace Mammography

Whole-Body CT Scan

• Not recommended for routine surveillance in asymptomatic breast cancer survivors 1
• Does not improve survival outcomes or quality of life 1
• Should only be ordered if disease recurrence is suspected based on symptoms 1
• Randomized trials from the 1980s showed no survival advantage with advanced imaging and demonstrated significant false-positive findings 1

Breast Ultrasound

• Not a substitute for mammography in screening 4
• Insufficient evidence to support routine screening ultrasound in this setting 4
• May be considered as supplemental imaging only in specific high-risk scenarios (e.g., dense breasts with additional risk factors), but does not replace mammography 1

Specific Recommendations for This Patient

At 3 years post-treatment, this patient should receive:

1. Annual mammography of the right breast (the intact, contralateral breast) 1, 2, 1
2. Clinical breast examination every 6-12 months (years 3-5 post-treatment) 1, 2
3. No routine imaging of the left mastectomy site unless reconstruction was performed or symptoms develop 1

Important Caveats

When MRI Might Be Added

MRI screening of the remaining breast should only be considered if the patient meets high-risk criteria 1, 2, 1:

• Lifetime risk of second primary breast cancer >20%
• BRCA1/BRCA2 mutation carrier
• Strong family history of breast cancer
• History of chest radiation therapy (e.g., for Hodgkin lymphoma)

Mastectomy Site Imaging

The ACR Appropriateness Criteria confirm there is insufficient evidence to support routine mammography of the post-mastectomy side 4. The left mastectomy site does not require imaging unless:

• Reconstruction was performed (then clinical examination is sufficient)
• Symptoms or palpable abnormalities develop 4

Clinical Pitfall to Avoid

Do not assume that whole-body CT or breast ultrasound provides adequate surveillance. These modalities have not been validated for breast cancer screening in survivors and may lead to false reassurance. Mammography remains the gold standard for detecting early contralateral breast cancers and is the only imaging modality recommended for routine surveillance in asymptomatic breast cancer survivors 1, 3.

The evidence is clear and consistent across multiple high-quality guidelines: annual mammography of the intact right breast should continue as part of standard survivorship care, regardless of other imaging studies performed 1, 2, 1, 5.